NOVO.B

Market closed
Access this stock data via API
Subscribe
Novo Nordisk A/S
0
0
0%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 75.0B 76.9B 78.1B 85.7B
Cost of revenue 17.9B 12.8B 12.9B 13.0B
Gross profit 57.1B 64.0B 65.2B 72.7B
Operating expense
Research & development 15.4B 11.7B 10.3B 13.8B
Selling general and admin 17.9B 18.8B 16.1B 20.3B
Other operating expenses 117M 23M -14M 1.8B
Operating income 23.7B 33.4B 38.8B 36.7B
Non operating interest income
Income 1.8B 5.3B 3.4B -447M
Expense 5.0B 5.2B -613M
Other income expense
Pretax income 25.5B 33.8B 37.0B 35.6B
Tax provision 5.5B 7.3B 8.0B 7.3B
Net income 20.0B 26.5B 29.0B 28.2B
Basic EPS 6.0 6.5
Diluted EPS 6.0 6.5
Basic average shares 4.4B 4.4B
Diluted average shares 4.4B 4.4B
EBITDA 31.4B 43.6B 46.0B 34.9B
Net income from continuing op. 20.0B 26.5B 29.0B 28.2B
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 5 hours 28 minutes

03:31
00:00
09:00
17:00
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 17:00
All times are displayed in the Europe/Copenhagen timezone (CET, UTC+01:00).